866-997-4948(US-Canada Toll Free)

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017

Published By :

Global Markets Direct

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 98 Pages

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017, provides an overview of the Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline landscape.

Chemotherapy induced nausea and vomiting or CINV is nausea and vomiting that results specifically from treatment with chemotherapy drugs. Symptoms include a rapid heart rate, sweating, dizziness and increased saliva. Risk factors include age, drug, dose, schedule of administration and route.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 1, 2, 6, 3, 1, 11, 3 and 3 respectively.

Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Chemotherapy Induced Nausea and Vomiting (Toxicology).
- The pipeline guide reviews pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Chemotherapy Induced Nausea and Vomiting - Overview 6
Chemotherapy Induced Nausea and Vomiting - Therapeutics Development 7
Pipeline Overview 7
Pipeline by Companies 8
Products under Development by Companies 11
Chemotherapy Induced Nausea and Vomiting - Therapeutics Assessment 13
Assessment by Target 13
Assessment by Mechanism of Action 15
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Chemotherapy Induced Nausea and Vomiting - Companies Involved in Therapeutics Development 20
Acacia Pharma Ltd 20
Aphios Corp 20
Astellas Pharma Inc 21
Athenex Inc 21
Camurus AB 22
Daewoong Pharmaceutical Co Ltd 22
Heron Therapeutics Inc 23
Insys Therapeutics Inc 23
Kyowa Hakko Kirin Co Ltd 24
MannKind Corp 24
Medlab Clinical Ltd 25
N4 Pharma Plc 25
Nanoform Cardiovascular Therapeutics Ltd 26
Nemus Bioscience Inc 26
RedHill Biopharma Ltd 27
Serina Therapeutics Inc 27
SoluBest Ltd 28
Suda Ltd 28
Tesaro Inc 29
Therapix Biosciences Ltd 29
Chemotherapy Induced Nausea and Vomiting - Drug Profiles 30
(netupitant + palonosetron hydrochloride) - Drug Profile 30
(palonosetron hydrochloride + Pro-netupitant) - Drug Profile 34
APD-403 - Drug Profile 35
aprepitant - Drug Profile 37
aprepitant - Drug Profile 38
aprepitant - Drug Profile 39
aprepitant - Drug Profile 40
aprepitant - Drug Profile 41
aprepitant - Drug Profile 42
Cannabis CINV - Drug Profile 43
dexamethasone - Drug Profile 44
dronabinol - Drug Profile 45
dronabinol - Drug Profile 46
FK-886 - Drug Profile 47
fosnetupitant - Drug Profile 49
granisetron hydrochloride - Drug Profile 50
granisetron hydrochloride - Drug Profile 51
granisetron hydrochloride - Drug Profile 52
granisetron hydrochloride ER - Drug Profile 53
LPI-1504 - Drug Profile 55
LPI-1505 - Drug Profile 56
NB-1222 - Drug Profile 57
NB-2111 - Drug Profile 58
netupitant - Drug Profile 59
ondansetron hydrochloride - Drug Profile 60
ondansetron hydrochloride - Drug Profile 62
ondansetron hydrochloride - Drug Profile 63
ondansetron hydrochloride - Drug Profile 64
ondansetron hydrochloride CR - Drug Profile 65
palmidrol - Drug Profile 72
palonosetron hydrochloride - Drug Profile 73
rolapitant hydrochloride - Drug Profile 74
SER-232 - Drug Profile 80
Zindol - Drug Profile 81
Chemotherapy Induced Nausea and Vomiting - Dormant Projects 82
Chemotherapy Induced Nausea and Vomiting - Discontinued Products 83
Chemotherapy Induced Nausea and Vomiting - Product Development Milestones 84
Featured News & Press Releases 84
Appendix 94
Methodology 94
Coverage 94
Secondary Research 94
Primary Research 94
Expert Panel Validation 94
Contact Us 94
Disclaimer 95

List of Tables
Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Acacia Pharma Ltd, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Aphios Corp, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Astellas Pharma Inc, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Athenex Inc, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Camurus AB, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Daewoong Pharmaceutical Co Ltd, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Heron Therapeutics Inc, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Insys Therapeutics Inc, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Kyowa Hakko Kirin Co Ltd, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by MannKind Corp, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Medlab Clinical Ltd, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by N4 Pharma Plc, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Nanoform Cardiovascular Therapeutics Ltd, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Nemus Bioscience Inc, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by RedHill Biopharma Ltd, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Serina Therapeutics Inc, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by SoluBest Ltd, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Suda Ltd, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Tesaro Inc, H2 2017
Chemotherapy Induced Nausea and Vomiting - Pipeline by Therapix Biosciences Ltd, H2 2017
Chemotherapy Induced Nausea and Vomiting - Dormant Projects, H2 2017
Chemotherapy Induced Nausea and Vomiting - Discontinued Products, H2 2017

List of Figures
Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Top 10 Routes of Administration, H2 2017
Number of Products by Stage and Top 10 Routes of Administration, H2 2017
Number of Products by Stage and Molecule Types, H2 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *